Projects per year
Personal profile
Education/Academic qualification
Master
Fingerprint
Dive into the research topics where Elisa Ardizzoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
TB/NTM Research Cluster
de Jong, B., Sengstake, S., Rigouts, L., Tzfadia, O., Ardizzoni, E., Lynen, L., Decroo, T., Hasker, E., Van Rie, A. & Janssens, N.
Fonds voor Wetenschappelijk Onderzoek
1/01/22 → 31/12/26
Project: Research Project
-
EndTB-Q: EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilones
de Jong, B., Ardizzoni, E. & Janssens, N.
1/07/20 → 30/04/24
Project: Research Project
-
-
End TB Clin.Trial Output 2
de Jong, B., Janssens, N. & Ardizzoni, E.
1/06/16 → 31/05/23
Project: Research Project
-
Improving detection of drug-resistant tuberculosis (TB by use of novel phenotypic and genotypic tests
Ardizzoni, E., de Jong, B., Rigouts, L. & Varraine, F.
1/01/13 → …
Project: PhD-project
-
Middlebrook 7H11 reduces invalid results and turnaround time of phenotypic drug susceptibility testing of M. tuberculosis
Rupasinghe, P., Vereecken, J., Decroo, T., Ardizzoni, E., Hewison, C., Huerga, H., Mesic, A., Rigouts, L. & de Jong, B., Jun-2022.Research output: Contribution to conference › Poster
-
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Antimycobacterial Susceptibility T, 2022, In: European Respiratory Journal. 59, 4, 11 p., 2200166.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, E., Berikova, E., Bonnet, M., Chang, E., Cloez, S., Coit, J. M., Cox, J., de Jong, B. C., Delifer, C., Do, J. M., Tozzi, D. D. S., Ducher, Ferlazzo, G., Gouillou, M., Khan, A., Khan, U., Lachenal, N. & 24 others, , 2021, In: Trials. 22, 1, 15 p., 651.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile9 Downloads (Pure) -
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
Guglielmetti, L., Ardizzoni, E., Baudin, E., de Jong, B., Bonnet, M., Ferlazzo, G., Rupasinghe, P., Seung, K. J., Lachenal, N., Wasserman, S., Varaine, F. & Mitnick, C. D., 2021, In: Trials. 22, 1Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests
Ardizzoni, E., Ariza, E., Mulengwa, D., Mpala, Q., de la Tour, R., Maphalala, G., Varaine, F., Kerschberger, B., Graulus, P., Page, A. L., Niemann, S., Dreyer, A., Van Deun, A., Decroo, T., Rigouts, L. & de Jong, B. C., 2021, In: Antimicrobial Agents and Chemotherapy. 65, 6, 11 p., e02263-20.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile34 Downloads (Pure)